BioAesthetics Doubles Initial $2.5M Funding Target & Welcomes New Director
BioAesthetics Announces Close of Series A, Doubles Initial $2.5M Target and Welcomes New Director RESEARCH TRIANGLE PARK, NC. (Jan. 11, 2021) — BioAesthetics Corporation today announced that it has doubled its initial…
BioFund Portfolio Company, BIoAesthetics, Lands University Clinical Study
BioAesthetics Announces University Clinical Study for its Nipple Reconstruction Graft NACgraft Aims to Improve Quality-of-Life for Breast Cancer Patients RESEARCH TRIANGLE PARK, NC. (Dec. 3, 2020) — BioAesthetics Corporation yesterday…
AxoSim Receives Investment from Benson Capital Partners
Benson Capital Partners Announces First Investment in AxoSim, Inc. AxoSim, Inc, Provider of BrainSim™ & NerveSim™ Neurological Drug Discovery Platforms, and BioFund Portfolio Company, Teams with Benson Capital Partners &…
NOBIC Tenant AxoSim Awarded $870K in Federal Funding
PRESS RELEASE: AxoSim Announces the Award of Over $870K in Federal Grants Overview –Two grants from the DoD Congressionally Directed Medical Research Program and the National Institutes of Health…
LSU HSCNO Spin-Out Awarded $1.9M in STTR Fast Track Funding
NIH STTR GRANT TO FAST TRACK NEW CLASS OF PAIN RELIEVER WITHOUT ADDICTION OR TOXICITY New Orleans, LA – The National Institute of Neurological Disorders and Stroke of the National…
MAJOR NEWS: NOBIC wins $1.5M EDA Award
New Orleans BioInnovation Center Awarded $1.5 Million Grant from U.S. EDA Incubator anticipates creating or retaining 650 jobs and attracting $75 million in private capital NEW ORLEANS (Sep. 17, 2020)…
NOTICE: Donations for Hurricane Laura Evacuees
Donations for Hurricane Laura Evacuees The New Orleans Health Department and the New Orleans Office of Homeland Security and Emergency Preparedness are working with DCFS to identify evacuee needs that…
AxoSim is Hiring
AxoSim is Hiring Are you looking for a fulfilling career in neurological drug discovery at a rapidly growing startup? AxoSim is looking for a Postdoctoral Researcher and a Research Associate!…
BARDA Update: TMC Innovation Event
BARDA Update: TMC Innovation Event The eradication of any novel biological threat demands the development of groundbreaking technologies and treatments in our biomedical ecosystem. In the face of SARS-CoV-2, the…
Community Update: Ochsner Vaccine Trial
Community Update: Ochsner Vaccine Trial Ochsner was selected as 1 of 73 sites around the world to test Pfizer’s COVID-19 vaccine. In total, Pfizer has received over $1B in funding…